Observational studyMedicine2020

Utility of neutrophil-to-lymphocyte ratio to identify long-term survivors among HCC patients treated with sorafenib.

Andrea Casadei-Gardini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.